Real-world Use of Molecular Point-of-care Testing for Sexually Transmitted Infections (STIs) in the Emergency Department: Why It Matters for Acute Care Management - Scorecard - MDSpire
Advertisement
Real-world Use of Molecular Point-of-care Testing for Sexually Transmitted Infections (STIs) in the Emergency Department: Why It Matters for Acute Care Management
Clinical Scorecard: Practical Application of Molecular Point-of-Care Testing for Sexually Transmitted Infections in Emergency Departments: Implications for Acute Care Management
Rapid molecular point-of-care polymerase chain reaction (PCR) testing enabling definitive diagnosis and targeted treatment during emergency department visits
Target Population
Female patients presenting to emergency departments with suspected STIs
Care Setting
Emergency department clinical setting with integrated point-of-care testing laboratory
Key Highlights
Point-of-care PCR testing significantly reduced emergency department length of stay by approximately 76 minutes (9.3%).
POC testing lowered overtreatment rates for Chlamydia trachomatis by 73% and Neisseria gonorrhoeae by 63%.
POC testing was associated with a 67% lower rate of undertreatment for any CT/NG/TV-positive cases, though not statistically significant due to small sample size.
Guideline-Based Recommendations
Diagnosis
Utilize FDA-cleared CLIA-waived molecular POC PCR assays for rapid detection of CT, NG, and TV in female ED patients.
Replace syndromic diagnosis and presumptive treatment with organism-specific molecular testing to improve diagnostic accuracy.
Management
Implement POC PCR testing to enable targeted antimicrobial therapy based on definitive test results during the ED visit.
Avoid empiric antimicrobial treatment when rapid molecular test results are available to reduce overtreatment and antimicrobial resistance.
Monitoring & Follow-up
Monitor rates of overtreatment and undertreatment to evaluate effectiveness of POC testing integration.
Track emergency department length of stay as a key operational metric impacted by testing modality.
Risks
Consider potential barriers to widespread adoption including higher per-sample costs and need for ED workflow integration.
Be aware of limitations in statistical power for undertreatment reduction due to small sample sizes in pilot studies.
Patient & Prescribing Data
Female emergency department patients tested for CT, NG, and TV
POC PCR testing enables organism-specific targeted treatment, significantly reducing overtreatment and potentially reducing undertreatment compared to central laboratory testing.
Clinical Best Practices
Incorporate FDA-cleared multiplex POC PCR assays into ED workflows to provide rapid, accurate STI diagnosis.
Train ED staff to perform CLIA-waived POC molecular testing to facilitate timely results and treatment decisions.
Use POC testing results to guide antimicrobial prescribing, minimizing unnecessary antibiotic use.
Evaluate operational impacts such as ED length of stay when implementing POC testing programs.
Address logistical challenges including cost and workflow integration to support sustainable POC testing adoption.
by Gaby Dashler, Kendall Maliszewski, Mustapha Saheed, Edana Mann, Nyah Johnson, Spencer J Mann, Tracy Colburn, William Clarke, Charlotte A Gaydos, Yukari C Manabe, K Davina Frick, Richard E Rothman, Yu-Hsiang Hsieh
